Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 2Phase 3 1

Status

Completed 3Recruiting 2Withdrawn 1

Sponsor Class

OTHER 5OTHER_GOV 1

Study Type

Interventional 6

Sponsor

Cancer Type

Sarcoma 6Gynecologic 6Gastrointestinal 6Thoracic 5Plasma cell 4Lymphoid 3Head & Neck 3Genitourinary 3Dermatologic 3CNS 3Tumor-Agnostic 1Other solid neoplasm 1Other hematologic neoplasm 1

Conditions

Uterine Cervical Neoplasms 3Vulvar Neoplasms 1Uterine Cervical Dysplasia 1Ovarian Neoplasms 1Neoplasms 1Adenocarcinoma 1Acidemia, isovaleric 1

Interventions

Paclitaxel 575Carboplatin 521Cisplatin 351Bevacizumab 252pembrolizumab 228Gemcitabine 157Topotecan 128Cyclophosphamide 128liposomal doxorubicin 127olaparib 120Taxes 113Radiotherapy 110Docetaxel 94Brachytherapy 89Doxorubicin 84Drug Therapy 81niraparib 75Nivolumab 71Magnetic Resonance Spectroscopy 71Specimen Handling 65fludarabine 57Biopsy 55Hyperthermic Intraperitoneal Chemotherapy 53Filgrastim 52Letrozole 50Oxaliplatin 48durvalumab 47Immunoglobulin G 47atezolizumab 46Platinum 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Nelfinavir × Gynecologic × Clear all
NCT04169763 2026-05-20

Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery

M.D. Anderson Cancer Center

Phase 1 Recruiting
25 enrolled
Gynecologic

Vulvar Neoplasms

NCT03256916 2026-02-24

NELCER

Tata Memorial Hospital

Phase 3 Completed
348 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT06971744 2025-12-22

Autophagy Maintenance (AUTOMAIN)

Medical University of South Carolina

Phase 2 Recruiting
38 enrolled
Gynecologic

Ovarian Neoplasms

NCT01925378 2020-11-12

A Phase II Single-arm Intervention Trial of Nelfinavir in Patients With Grade 2/3 or 3 Cervical Intraepithelial Neoplasia

The University of Texas Health Science Center, Houston

Phase 2 Withdrawn
Gynecologic

Uterine Cervical Dysplasia

NCT02363829 2020-04-06

A Study of Nelfinavir Added to Cisplatin Chemotherapy Concurrent With Pelvic Radiation for Locally Advanced Cervical Cancer (II-IVA)

Abramson Cancer Center at Penn Medicine

Phase 1 Completed
6 enrolled
Gynecologic

Acidemia, isovaleric, Uterine Cervical Neoplasms

NCT01485731 2015-06-03

Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer

University of Miami

Phase 1 Completed
8 enrolled
Gynecologic

Adenocarcinoma, Uterine Cervical Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡